InsidersTradesSigma
Paxman AB (publ): insider trades · Finland · FIN-FSA
FI:paxman-ab-publSE0009806284FI·FIN-FSAMcap 1.2Bn€Healthcare
Discover the full directors' dealings record of Paxman AB (publ), a listed issuer based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Paxman AB (publ) has recorded 10 reports. Market capitalisation: €1.2bn. The latest transaction was reported on 16 November 2025 — Purchase. Among the most active insiders: Per-Anders Johansson. Every trade is accessible without an account.
10
Insider Decl.
0
Thresholds
€156,922
9 ops.
Buy Volume
€11m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
50.00 €
Analyst consensus
2 analystsStrong buy
82.00 €Target 92.50 €(+85%)103.00 €
Income statement
Revenue313.3 M€
Gross profit208.8 M€67% margin
Net income−16.7 M€-5.2% margin
Valuation
PER (forward)12.1x
P/Book2.9x
Beta0.45
Balance sheet & cash
Market cap1.16 Bn€
Total debt13.0 M€
Free Cash Flow−16.1 M€
Debt / Equity3%
Profitability & ownership
ROE-5.9%
ROA0.8%
% insiders42.6%
% institutions19.7%
Last declaration on 16 November 2025
Declarations10 total
Executives●Purchase15FIN-FSA
€13,4782,500 shares@ €5.39120.0012% mcap25.1% of flow
Aktie
FI:A003T691-1·
Ideal exit: 11 Aug 2026 (T+270)
Executives●Purchase36FIN-FSA
€90,62914,880 shares@ €6.09070.0078% mcap100.0% of flow
Aktie
FI:A003S578-1·
Ideal exit: 20 Jun 2026 (T+270)
Executives●Sale32FIN-FSA
€11m1,850,000 shares@ €6.09070.97% mcap100.0% of flow
Aktie
FI:A003S584-1·
Executives●Purchase32FIN-FSA
€12,6692,080 shares@ €6.09070.0011% mcap100.0% of flow
Aktie
FI:A003S569-1·
Ideal exit: 20 Jun 2026 (T+270)
Executives●Purchase12FIN-FSA
015,122 shares0
Teckningsoption
FI:A003S236-2·
Ideal exit: 9 Jun 2026 (T+270)
Executives●Purchase12FIN-FSA
018,788 shares0
Teckningsoption
FI:A003S232-1·
Ideal exit: 9 Jun 2026 (T+270)
Executives●Purchase12FIN-FSA
010,000 shares0
Teckningsoption
FI:A003S233-1·
Ideal exit: 9 Jun 2026 (T+270)
Executives●Purchase12FIN-FSA
017,576 shares0
Teckningsoption
FI:A003S225-1·
Ideal exit: 9 Jun 2026 (T+270)
Executives●Purchase13FIN-FSA
€7,8211,100 shares@ €7.11030.0007% mcap14.6% of flow
Aktie
FI:A003R939-1·
Ideal exit: 29 May 2026 (T+270)
Executives●Purchase18FIN-FSA
€32,3255,000 shares@ €6.46510.0028% mcap60.3% of flow
Aktie
FI:A003O480-1·
Ideal exit: 10 Feb 2026 (T+270)
10 of 10 declarations